NCT03493620

Brief Summary

Obesity is a chronic disease that has grown to epidemic proportions in Brazil and throughout the world in recent years. Bariatric surgery has been the most effective method for the treatment and prophylaxis of complications caused by morbid obesity, thereby increasing the longevity and quality of life of patients. The treatment of patients with Class III obesity or higher or Class II with comorbidities is already well established with bariatric surgery being the best option. However, there is no consensus as to the best treatment in cases of Class I or II obesity without comorbidities. The objective of this research will be to make a gastric tube similar to that obtained by surgical gastroplication but using endoscopic intragastric sutures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started Jan 2018

Typical duration for not_applicable obesity

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 8, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 14, 2018

Completed
27 days until next milestone

First Posted

Study publicly available on registry

April 10, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2020

Completed
Last Updated

August 17, 2022

Status Verified

August 1, 2022

Enrollment Period

1.6 years

First QC Date

March 14, 2018

Last Update Submit

August 16, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Weight loss

    weight in kg

    outcome will be evaluated for 2 years

Secondary Outcomes (3)

  • Weight maintenance

    2 years

  • Surgical related complications

    2 years

  • Comorbidities

    2 years

Study Arms (2)

Device arm

EXPERIMENTAL

Gastric endosuturing will be performed until the entire gastric body is sutured in the form of a tube.

Procedure: Device arm

Sham arm

SHAM COMPARATOR

Group II is a control group (only the endoscopist will know which group each patient belongs to)

Procedure: Sham arm

Interventions

Device armPROCEDURE

Make a gastric tube (endoscopic sleeve gastroplasty) using the Apollo Overstitch suturing device through endoscopy.

Device arm
Sham armPROCEDURE

Group II will be conducted identically to Group I except for the procedure itself, and only the endoscopist, that is the researcher, will be aware of which group each patient belongs to.

Sham arm

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged over 18 years,
  • BMI \> 30 and \< 36 kg/m2, with or without comorbidities,
  • BMI \> 36 and \< 40 without comorbidities

You may not qualify if:

  • Previous gastric surgery
  • Taking anticoagulant drugs
  • Psychiatric disorders
  • Severe esophagitis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Faculty of Medicine of ABC

Santo André, São Paulo, Brazil

Location

Kaiser Clinic and Day Hospital

São José do Rio Preto, São Paulo, Brazil

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Luiz Gustavo de Quadros, MD

    Kaiser Clinica and Day Hospital

    PRINCIPAL INVESTIGATOR
  • Eduardo Grecco, MD

    ABC Medical School

    PRINCIPAL INVESTIGATOR
  • Manoel Galvao Neto, MD

    ABC Medical School

    PRINCIPAL INVESTIGATOR
  • Thiago Ferreira de Souza, PhD

    ABC Medical School

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 14, 2018

First Posted

April 10, 2018

Study Start

January 8, 2018

Primary Completion

August 1, 2019

Study Completion

August 1, 2020

Last Updated

August 17, 2022

Record last verified: 2022-08

Locations